Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies999
Neuromed Pharmaceuticals
Neuromed Pharmaceuticals is a biopharmaceutical company that specializes in the development and sale of pain therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is an Asia-based biotech company that develops immuno-oncology agents and targeted therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
OncBioMune
OncBioMune is a biopharmaceutical firm focused on creating innovative cancer treatments and immune system-boosting vaccines.
Sector
Subsector
Keywords
Location
Ionix Pharmaceuticals
Ionix Pharmaceuticals develops new analgesic medicines for pain treatment.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Merck Sharp & Dohme Sweden AB
announced date
price
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 08.07.2015. Their latest investor Domain Associates. Their latest round Series C
Tekla Capital Management
Tekla Capital Management is a Boston-based investment adviser that specializes in healthcare and life sciences equity funds.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Redmile Group
Redmile Group is a San Francisco-based healthcare investment company.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Partner Fund Management
Partner Fund Management offers services to investment funds.
Sector
Subsector
Location
count Of Investments
count Of Exists
Fidelity Management and Research Company
Fidelity Management and Research Company is a private investment manager that aims to make financial expertise accessible to everyone.
Sector
Subsector
Location
count Of Investments
count Of Exists
Jennison Associates
Jennison Associates is a wealth management firm that has been fulfilling client investment needs since 1969.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Third Rock Ventures
Third Rock Ventures invests in high-growth potential life science companies that can make a difference in the marketplace.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Domain Associates
Domain Associates is a venture capital firm that invests exclusively in life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Jesse I. Treu
Jesse I. Treu is the Board Member at Veracyte Inc. Dr. Treu has been a Partner of Domain since its inception in 1985. He has been a director of more than 30 early-stage healthcare companies, 18 of which have so far become successful public companies. At present, his board memberships include Afferent Pharmaceuticals, CoLucid Pharmaceuticals, Regado Biosciences, Tandem Diabetes Care and Veracyte. He has served as a Founder, President and Chairman of numerous venture stage companies. Prior to the formation of Domain, Dr. Treu was vice president of the predecessor organization to The Wilkerson Group, and its venture capital arm, CW Ventures. While at CW Ventures, he served as President and CEO of Microsonics, a pioneer in computer image processing for cardiology. Prior to that, Dr. Treu held executive positions at Technicon Instruments Corporation (now Siemens Medical Solutions Diagnostics), and at GE. Education: B.S. - Rensselaer Polytechnic Institute, 1968 M.A. & Ph.D. - Princeton University, 1971, 1973
current job
Third Rock Ventures
Third Rock Ventures invests in high-growth potential life science companies that can make a difference in the marketplace.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Kevin Starr
Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development, and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Before Third Rock Ventures, Mr. Starr was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen, and Digital Equipment Corporation. He is currently a Board Member and Start-Up CEO of Sage Therapeutics. Mr. Starr holds an M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.
current job
Pappas Ventures
Pappas Ventures is a venture capital firm that focuses on investing in early-stage life science companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Artthur M. Pappas
Arthur M. Pappas, MBA, founder and managing partner of the Research Triangle Park venture capital firm Pappas Ventures, has been elected chairman of the North Carolina Biotechnology Center's Board of Directors.
current job
organization founded
People
Founders1
Anthony P. Ford
Dr. Ford is co-founder and chief scientific officer of Afferent. An accomplished pharmacologist and former vice president of research at Roche, Dr. Ford initiated and drove the P2X3 program at Roche for over a decade. Dr. Ford brings more than 20 years of research and development experience at Roche and Syntex to Afferent, having led the progression of several novel drug candidates into early clinical development, focused particularly in the areas of pain and genitourinary therapeutics. Dr. Ford was trained in neuropharmacology and holds a Ph.D. from the University of Nottingham (UK).
current job
organization founded
Anthony P. Ford
Employee Profiles8
Anthony P. Ford
Co-Founder and Chief Scientific Officer